Charles Schwab’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,178
| Closed | -$167K | – | 3648 |
|
|
2022
Q4 | $167K | Hold |
11,178
| – | – | ﹤0.01% | 3211 |
|
|
2022
Q3 | $92K | Sell |
11,178
-6,002
| -35% | -$46.1K | ﹤0.01% | 3232 |
|
|
2022
Q2 | $113K | Hold |
17,180
| – | – | ﹤0.01% | 3279 |
|
|
2022
Q1 | $97K | Hold |
17,180
| – | – | ﹤0.01% | 3421 |
|
|
2021
Q4 | $81K | Hold |
17,180
| – | – | ﹤0.01% | 3464 |
|
|
2021
Q3 | $107K | Buy |
+17,180
| New | +$103K | ﹤0.01% | 3374 |
|
|
2021
Q2 | – | Sell |
-55,282
| Closed | -$405K | – | 3637 |
|
|
2021
Q1 | $405K | Sell |
55,282
-2,582
| -4% | -$22.3K | ﹤0.01% | 3149 |
|
|
2020
Q4 | $334K | Buy |
57,864
+9,719
| +20% | +$55.6K | ﹤0.01% | 3117 |
|
|
2020
Q3 | $286K | Buy |
48,145
+15,936
| +49% | +$78.8K | ﹤0.01% | 3045 |
|
|
2020
Q2 | $166K | Buy |
+32,209
| New | +$203K | ﹤0.01% | 3194 |
|
|
2020
Q1 | – | Sell |
-2,863
| Closed | -$18K | – | 3257 |
|
|
2019
Q4 | $18K | Hold |
2,863
| – | – | ﹤0.01% | 3162 |
|
|
2019
Q3 | $25K | Hold |
2,863
| – | – | ﹤0.01% | 3152 |
|
|
2019
Q2 | $20K | Sell |
2,863
-20,103
| -88% | -$172K | ﹤0.01% | 3201 |
|
|
2019
Q1 | $189K | Hold |
22,966
| – | – | ﹤0.01% | 3033 |
|
|
2018
Q4 | $368K | Buy |
22,966
+1,153
| +5% | +$25.4K | ﹤0.01% | 2869 |
|
|
2018
Q3 | $723K | Hold |
21,813
| – | – | ﹤0.01% | 2719 |
|
|
2018
Q2 | $493K | Buy |
21,813
+18,950
| +662% | +$449K | ﹤0.01% | 2809 |
|
|
2018
Q1 | $84K | Hold |
2,863
| – | – | ﹤0.01% | 3052 |
|
|
2017
Q4 | $80K | Buy |
+2,863
| New | +$88.9K | ﹤0.01% | 3042 |
|
|
2016
Q3 | – | Sell |
-1,510
| Closed | -$15K | – | 3056 |
|
|
2016
Q2 | $15K | Hold |
1,510
| – | – | ﹤0.01% | 3094 |
|
|
2016
Q1 | $14K | Hold |
1,510
| – | – | ﹤0.01% | 3050 |
|
|
2015
Q4 | $20K | Hold |
1,510
| – | – | ﹤0.01% | 3088 |
|
|
2015
Q3 | $19K | Hold |
1,510
| – | – | ﹤0.01% | 3081 |
|
|
2015
Q2 | $27K | Hold |
1,510
| – | – | ﹤0.01% | 3078 |
|
|
2015
Q1 | $22K | Hold |
1,510
| – | – | ﹤0.01% | 3076 |
|
|
2014
Q4 | $13K | Hold |
1,510
| – | – | ﹤0.01% | 3102 |
|
|
2014
Q3 | $17K | Hold |
1,510
| – | – | ﹤0.01% | 3066 |
|
|
2014
Q2 | $28K | Sell |
1,510
-6,490
| -81% | -$84.4K | ﹤0.01% | 3075 |
|
|
2014
Q1 | $120K | Hold |
8,000
| – | – | ﹤0.01% | 3024 |
|
|
2013
Q4 | $148K | Hold |
8,000
| – | – | ﹤0.01% | 3023 |
|
|
2013
Q3 | $167K | Sell |
8,000
-2,380
| -23% | -$54.5K | ﹤0.01% | 2966 |
|
|
2013
Q2 | $266K | Buy |
+10,380
| New | +$444K | ﹤0.01% | 2779 |
|
Charles Schwab's AVEO Position: Q1 2023 in Review
Charles Schwab sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 11,178 shares — an estimated $167K sold.
Charles Schwab first reported a position in AVEO in Q2 2013 and held it in 32 quarters. The position peaked at $723K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Charles Schwab reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Charles Schwab sold 11,178 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $167K.
- Charles Schwab first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 32 quarters.
- Charles Schwab's AVEO Pharmaceuticals, Inc. position peaked at $723K in Q3 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.